Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA (SOPH), sold 216 shares at $8.06 ($2K) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Open-market sale of $2k SOPH by Chief Sales Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.92 | 31 | $246 | 14.1% |
| 2 | $8.06 | 185 | $1K | 85.9% |
| Total | $8.04 avg | 216 | $2K | 100% |
| Filing → |
| SOPH | SELL | 2026-04-21 | $168 | — | Filing → |
| SOPH | SELL | 2026-04-08 | $3K | — | Filing → |
| SOPH | SELL | 2026-04-01 | $14 | — | Filing → |